Antidepressant effects of Soyo-san on immobilization stress in ovariectomized female rats

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 8, 2007, Pages 1422-1426

  Oh, Jin Kyung ^a   Kim, Yoon Sang ^b   Park, Hyun Jung ^c   Lim, Eun Mee ^b   Pyun, Kwang Ho ^c   Shim, Insop ^c  

^a Kyung Hee University   (South Korea)

^b Kyung Won University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Choline acetyltransferase; Depression; Elevated pulse maze; Morris water maze; Ovariectomy; Soyo san

Indexed keywords

ACETYLCHOLINESTERASE; ANTIDEPRESSANT AGENT; CHOLINE ACETYLTRANSFERASE; CORTICOSTERONE; SOYO SAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; IMMOBILIZATION STRESS; IMMUNOCOMPETENT CELL; LEARNING; MAZE TEST; MEMORY; NONHUMAN; OVARIECTOMY; RAT; SPATIAL MEMORY; TRANQUILIZING ACTIVITY;

ACETYLCHOLINESTERASE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; CHOLINE O-ACETYLTRANSFERASE; CORTICOSTERONE; DATA INTERPRETATION, STATISTICAL; DRUGS, CHINESE HERBAL; FEMALE; IMMUNOHISTOCHEMISTRY; MAZE LEARNING; NEURONS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 34548041863     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1422     Document Type: Article

References (49)

1. Weissman M. M., Livingston B. M., Leaf P. J., Florio L. P., Holzer C. I., "Affective Disorders," ed. by Robins L. E., Regier D. A., The Free Press, New York, 1991, pp. 53-80.
2. Shors T. J., Leuner B., J. Affective Disorders, 74, 85-96 (2003).
3. Desmond N. L., Levy W. B., Hippocampus, 7, 239-245 (1997).
4. Smith C. C., Cizza G., Gomez M., Greibler C., Gold P. W., Sternberg E. M., Neuroimmunomodulation, 1, 231-235 (1994).
5. Woolley C. S., Curr. Opin. Neurobiol., 9, 349-354 (1999).
6. Kellendonk C., Gass P., Kretz O., Schutz G., Tronche F., Brain Res. Bull., 57, 73-83 (2002).
7. McEwen B. S., Ann. N.Y. Acad. Sci., 746, 134-142 (1994).
8. Sapolsky R. M., Biol. Psychiatry, 48, 755-765 (2000).
9. Sheline Y. I., Biol. Psychiatry, 48, 791-800 (2000).
10. Bremner J. D., Naraya M., Anderson E. R., Staib L. H., Am. J. Psychiatry, 157, 115-117 (2000).
11. Janowsky D. S., Overstreet D. H., "Psychopharmacology, The Fourth Generation of Progress," ed. by Bloom F. E., Kupfer D. J., Raven Press, New York, 1995, pp. 945-956.
12. Fibiger H. C., Damsma G., Day J. C., "The Basal Forebrain," ed. by Napier T. C., Kalivas P. W., Hanin I., Plenum Press, New York, 1991, pp. 399-414.
13. Fan D. H., Chin. Tradit. Herb. Drugs, 18, 44-45 (1996).
14. Zhao L. J., Chin. J. Hosp. Pharm., 3, 178-179 (2003).
15. Wang J. Y., Shi Y. H., Cha P. Z., Li F. Y., Chin. J. Hosp. Pharm., 22, 489-491 (2002).
16. Xu Z. W., Wu L. L., Yan C., Wang W. Z., Ao H. Q., Tradit. Chin. Med. Res., 16, 14-15 (2003).
17. Seligman M. E., J. Abnorm. Psychol., 87, 165-179 (1997).
18. Pellow S., Chopin P., File S. E., Briley M., J. Neurosci. Methods, 14, 149-167 (1985).
19. Paxinos G., Watson C., "The Rat Brain in Stereotaxic Coordinates," Academic, San Diego, 1986.
20. Weinstock M., Razin M., Schorer-Apelbaum D., Men D., McCarty R., Int. J. Dev. Neurosci., 16, 289-295 (1998).
21. Ehlert U., Gaab J., Heinrichs M., Biol. Psychol., 57, 141-152 (2001).
22. Young E. A., J. Gend. Specif. Med., 1, 21-27 (1998).
23. Frye C., Physiol. Behav., 57, 5-14 (1995).
24. Galea L. A., Kavaliers M., Ossenkopp K. P., Hampson E., Horm. Behav., 29, 106-125 (1995).
25. Hogervorst E., Williams J., Budge M., Riedel W., Jolles J., Neuroscience, 101, 485-512 (2000).
26. Viau V., Meaney M. J., Endocrinology, 129, 2503-2511 (1991).
27. Oitzl M. S., deKloet E. R., Behav. Neurosci., 106, 62-71 (1992).
28. Jacobson L., Sapolsk R., Endocr. Rev., 12, 118-164 (1991).
29. Diamond D. M., Park C. R., Heman K. L., Rose G. M., Hippocampus, 9, 542-552 (1999).
30. Wolf O. T., Schommer N. C., Hellhammer D. H., McEwen B. S., Kirschbaum C., Psychoneuroendocrinology, 26, 711-720 (2001).
31. Kim S. H., Han J., Seog D. H., Chung J. Y., Kim N., HongPark Y., Lee S. K., Life Sci., 76, 1297-1306 (2005).
32. Mizoguchi K., Yuzurihara M., Ishige A., Aburade M., Tabira T., Pharmacol. Biochem. Behav., 75, 419-425 (2003).
33. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Tabira T., Life Sci., 72, 67-77 (2003).
34. Chen S. W., Min L., Li W. J., Kong W. X., Li J. F., Zhang Y. J., Pharmacol. Biochem. Behav., 79, 377-382 (2004).
35. Matsumoto K., Kohno S., Ojima K., Tezuka Y., Kadota S., Watanabe H., Life Sci., 62, 2073-2082 (1998).
36. Toriizuka K., Kamiki H., Ohmura N. Y., Fujii M., Hori Y., Fukumura M., Hirai Y., Isoda S., Nemoto Y., Ida Y., Life Sci., 77, 3010-3020 (2005).
37. Liu T. P., Liu M., Tsai C. C., Lai T. Y., Hsu F. L., Cheng J. T., J. Pharm. Pharmacol., 54, 681-688 (2002).
38. Rodgers R. J., Dalvi A., Neurosci. Biobehav. Rev., 21, 801-810 (1997).
39. Cooper J. R., Bloom F. E., Roth R. H., "Acetylcholine, The Biochemical Basis of Neuropharmacology," Oxford University Press, New York, 2003, pp. 151-170.
40. Satoh K., Armstrong D. M., Fibiger H. C., Brain Res. Bull., 11, 693-720 (1983).
41. Mckinney M., Coyle J. T., Hedreen J. C., J. Comp. Neurol., 217, 103-121 (1983).
42. Huang Y. L., Onodera H., Takeda A., Itoyama Y., Kogure K., Brain Res., 722, 195-199 (1996).
43. Gottesfeld Z., Kvetnansky R., Kopin I. J., Jacobowitz D. M., Brain Res., 152, 374-378 (1978).
44. Longoni R., Mulas A., Novak B. O., Pepeu I. M., Pepeu G., Neuropharmacology, 15, 283-286 (1976).
45. Mitsushima D., Masuda J., Kimura F., Neuroendocrinology, 78, 234-240 (2003).
46. Woolley C. S., Gould E., McEwen B. S., Brain Res., 531, 225-231 (1990).
47. Pearlstein T., Rosen K., Stone A. B., Endocrinol. Metab. Clin. North Am., 26, 279-294 (1997).
48. Rubinow D. R., Schmidt P. J., Roca C. A., Biol. Psychiatry, 44, 839-850 (1998).
49. Burt V. K., Altshuler L. L., Rasgon N., Harv. Rev. Psychiatry, 6, 121-132 (1998).